Požymis
High blood pressure
Klinikinis pavadinimas: Hypertension
The presence of chronic increased pressure in the systemic arterial system.
Santrauka
- Taip pat vadinama
- Arterial hypertension, Systemic hypertension
- Kūno sistema
- Abnormality of the cardiovascular system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to High blood pressure, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test441 genas susijęs su High blood pressure
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia High blood pressure. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ACTN4actinin alpha 4 | Visada | 1 ligoje |
| ADRA2Aadrenoceptor alpha 2A | Visada | 1 ligoje |
| APOA1apolipoprotein A1 | Visada | 1 ligoje |
| APOA4apolipoprotein A4 | Visada | 1 ligoje |
| BBS2Bardet-Biedl syndrome 2 | Visada | 2 ligose |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Visada | 2 ligose |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Visada | 1 ligoje |
| CC2D2Acoiled-coil and C2 domain containing 2A | Visada | 1 ligoje |
| CEP19centrosomal protein 19 | Visada | 2 ligose |
| CIDECcell death inducing DFFA like effector c | Visada | 1 ligoje |
| CIROZciliated left-right organizer protein containing ZP-N domains | Visada | 1 ligoje |
| CLCN2chloride voltage-gated channel 2 | Visada | 2 ligose |
| CORINcorin, serine peptidase | Visada | 2 ligose |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Visada | 1 ligoje |
| DHCR77-dehydrocholesterol reductase | Visada | 1 ligoje |
| DYRK1Bdual specificity tyrosine phosphorylation regulated kinase 1B | Visada | 1 ligoje |
| ECE1endothelin converting enzyme 1 | Visada | 1 ligoje |
| EGFRepidermal growth factor receptor | Visada | 1 ligoje |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Visada | 2 ligose |
| FDXRferredoxin reductase | Visada | 1 ligoje |
| FEM1Bfem-1 homolog B | Visada | 1 ligoje |
| FGFR2fibroblast growth factor receptor 2 | Visada | 3 ligose |
| GUCY1A1guanylate cyclase 1 soluble subunit alpha 1 | Visada | 2 ligose |
| HMOX1heme oxygenase 1 | Visada | 2 ligose |
| HSD11B2hydroxysteroid 11-beta dehydrogenase 2 | Visada | 2 ligose |
| HSPB8heat shock protein family B (small) member 8 | Visada | 1 ligoje |
| IFT140intraflagellar transport 140 | Visada | 3 ligose |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Visada | 2 ligose |
| KDM6Blysine demethylase 6B | Visada | 1 ligoje |
| LAMB2laminin subunit beta 2 | Visada | 2 ligose |
| LYZlysozyme | Visada | 1 ligoje |
| MAFBMAF bZIP transcription factor B | Visada | 1 ligoje |
| MDM2MDM2 proto-oncogene | Visada | 1 ligoje |
| NRAPnebulin related anchoring protein | Visada | 1 ligoje |
| OAS22'-5'-oligoadenylate synthetase 2 | Visada | 1 ligoje |
| PDE3Aphosphodiesterase 3A | Visada | 2 ligose |
| PLD4phospholipase D family member 4 | Visada | 1 ligoje |
| PLIN1perilipin 1 | Visada | 2 ligose |
| PPARGperoxisome proliferator activated receptor gamma | Visada | 2 ligose |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Visada | 4 ligose |
Rodyti dar 401 geną
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| PSKH1protein serine kinase H1 | Visada | 1 ligoje |
| PTPMT1protein tyrosine phosphatase mitochondrial 1 | Visada | 1 ligoje |
| RAB32RAB32, member RAS oncogene family | Visada | 1 ligoje |
| RDH8retinol dehydrogenase 8 | Visada | 1 ligoje |
| RFC4replication factor C subunit 4 | Visada | 1 ligoje |
| RNU5B-1RNA, U5B small nuclear 1 | Visada | 1 ligoje |
| SCNN1Asodium channel epithelial 1 subunit alpha | Visada | 2 ligose |
| SCNN1Bsodium channel epithelial 1 subunit beta | Visada | 2 ligose |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Visada | 2 ligose |
| SGSM3small G protein signaling modulator 3 | Visada | 1 ligoje |
| SLC30A9solute carrier family 30 member 9 | Visada | 1 ligoje |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Visada | 2 ligose |
| WASWASP actin nucleation promoting factor | Visada | 1 ligoje |
| WNK1WNK lysine deficient protein kinase 1 | Visada | 1 ligoje |
| CEP164centrosomal protein 164 | Labai dažnai (80–99%) | 1 ligoje |
| CEP290centrosomal protein 290 | Labai dažnai (80–99%) | 2 ligose |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Labai dažnai (80–99%) | 4 ligose |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Labai dažnai (80–99%) | 1 ligoje |
| CYP17A1cytochrome P450 family 17 subfamily A member 1 | Labai dažnai (80–99%) | 2 ligose |
| DZIP1LDAZ interacting zinc finger protein 1 like | Labai dažnai (80–99%) | 2 ligose |
| FLT1fms related receptor tyrosine kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| FN1fibronectin 1 | Labai dažnai (80–99%) | 2 ligose |
| IFT54intraflagellar transport 54 | Labai dažnai (80–99%) | 1 ligoje |
| INVSinversin | Labai dažnai (80–99%) | 2 ligose |
| IQCB1IQ motif containing B1 | Labai dažnai (80–99%) | 1 ligoje |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 2 ligose |
| LMNAlamin A/C | Labai dažnai (80–99%) | 5 ligose |
| LMX1BLIM homeobox transcription factor 1 beta | Labai dažnai (80–99%) | 1 ligoje |
| NEK8NIMA related kinase 8 | Labai dažnai (80–99%) | 2 ligose |
| NPHP1nephrocystin 1 | Labai dažnai (80–99%) | 3 ligose |
| NPHP3nephrocystin 3 | Labai dažnai (80–99%) | 1 ligoje |
| NPHP4nephrocystin 4 | Labai dažnai (80–99%) | 1 ligoje |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Labai dažnai (80–99%) | 2 ligose |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Labai dažnai (80–99%) | 2 ligose |
| STOX1storkhead box 1 | Labai dažnai (80–99%) | 1 ligoje |
| WDR19WD repeat domain 19 | Labai dažnai (80–99%) | 1 ligoje |
| ABCB6ATP binding cassette subfamily B member 6 (LAN blood group) | Dažnai (30–79%) | 1 ligoje |
| ABCC6ATP binding cassette subfamily C member 6 | Dažnai (30–79%) | 5 ligose |
| ABCG5ATP binding cassette subfamily G member 5 | Dažnai (30–79%) | 1 ligoje |
| ABCG8ATP binding cassette subfamily G member 8 | Dažnai (30–79%) | 1 ligoje |
| ACTA2actin alpha 2, smooth muscle | Dažnai (30–79%) | 2 ligose |
| ADA2adenosine deaminase 2 | Dažnai (30–79%) | 3 ligose |
| AIPAHR interacting HSP90 co-chaperone | Dažnai (30–79%) | 3 ligose |
| ALG5ALG5 dolichyl-phosphate beta-glucosyltransferase | Dažnai (30–79%) | 2 ligose |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Dažnai (30–79%) | 1 ligoje |
| ALMS1ALMS1 centrosome and basal body associated protein | Dažnai (30–79%) | 2 ligose |
| ANGPTL6angiopoietin like 6 | Dažnai (30–79%) | 1 ligoje |
| APOBapolipoprotein B | Dažnai (30–79%) | 1 ligoje |
| APRTadenine phosphoribosyltransferase | Dažnai (30–79%) | 1 ligoje |
| ARL6ARF like GTPase 6 | Dažnai (30–79%) | 2 ligose |
| ARMC5armadillo repeat containing 5 | Dažnai (30–79%) | 2 ligose |
| ASLargininosuccinate lyase | Dažnai (30–79%) | 1 ligoje |
| ATRXATRX chromatin remodeler | Dažnai (30–79%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Dažnai (30–79%) | 1 ligoje |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Dažnai (30–79%) | 1 ligoje |
| BBIP1BBSome interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| BBS1Bardet-Biedl syndrome 1 | Dažnai (30–79%) | 2 ligose |
| BBS10Bardet-Biedl syndrome 10 | Dažnai (30–79%) | 1 ligoje |
| BBS12Bardet-Biedl syndrome 12 | Dažnai (30–79%) | 1 ligoje |
| BBS4Bardet-Biedl syndrome 4 | Dažnai (30–79%) | 1 ligoje |
| BBS5Bardet-Biedl syndrome 5 | Dažnai (30–79%) | 1 ligoje |
| BBS7Bardet-Biedl syndrome 7 | Dažnai (30–79%) | 1 ligoje |
| BBS9Bardet-Biedl syndrome 9 | Dažnai (30–79%) | 1 ligoje |
| BICC1BicC family RNA binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| BRCC3BRCA1/BRCA2-containing complex subunit 3 | Dažnai (30–79%) | 1 ligoje |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Dažnai (30–79%) | 1 ligoje |
| C3complement C3 | Dažnai (30–79%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CAV1caveolin 1 | Dažnai (30–79%) | 1 ligoje |
| CBScystathionine beta-synthase | Dažnai (30–79%) | 1 ligoje |
| CCND1cyclin D1 | Dažnai (30–79%) | 2 ligose |
| CD46CD46 molecule | Dažnai (30–79%) | 1 ligoje |
| CDH23cadherin related 23 | Dažnai (30–79%) | 2 ligose |
| CDKN2Acyclin dependent kinase inhibitor 2A | Dažnai (30–79%) | 1 ligoje |
| CELA2Achymotrypsin like elastase 2A | Dažnai (30–79%) | 1 ligoje |
| CEP83centrosomal protein 83 | Dažnai (30–79%) | 1 ligoje |
| CFAP418cilia and flagella associated protein 418 | Dažnai (30–79%) | 1 ligoje |
| CFBcomplement factor B | Dažnai (30–79%) | 1 ligoje |
| CFIcomplement factor I | Dažnai (30–79%) | 1 ligoje |
| CLDN16claudin 16 | Dažnai (30–79%) | 1 ligoje |
| CLIP2CAP-Gly domain containing linker protein 2 | Dažnai (30–79%) | 1 ligoje |
| COL3A1collagen type III alpha 1 chain | Dažnai (30–79%) | 2 ligose |
| COL4A5collagen type IV alpha 5 chain | Dažnai (30–79%) | 2 ligose |
| CR2complement C3d receptor 2 | Dažnai (30–79%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Dažnai (30–79%) | 2 ligose |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 1 ligoje |
| CTSAcathepsin A | Dažnai (30–79%) | 1 ligoje |
| CTSHcathepsin H | Dažnai (30–79%) | 1 ligoje |
| DCDC2doublecortin domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| DEF6DEF6 guanine nucleotide exchange factor | Dažnai (30–79%) | 1 ligoje |
| DGKEdiacylglycerol kinase epsilon | Dažnai (30–79%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Dažnai (30–79%) | 1 ligoje |
| DNAJB11DnaJ heat shock protein family (Hsp40) member B11 | Dažnai (30–79%) | 2 ligose |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Dažnai (30–79%) | 1 ligoje |
| DNASE1deoxyribonuclease 1 | Dažnai (30–79%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| DSTdystonin | Dažnai (30–79%) | 1 ligoje |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Dažnai (30–79%) | 1 ligoje |
| EIF4Heukaryotic translation initiation factor 4H | Dažnai (30–79%) | 1 ligoje |
| ELNelastin | Dažnai (30–79%) | 4 ligose |
| ELP1elongator acetyltransferase complex subunit 1 | Dažnai (30–79%) | 2 ligose |
| ENGendoglin | Dažnai (30–79%) | 1 ligoje |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Dažnai (30–79%) | 3 ligose |
| EPAS1endothelial PAS domain protein 1 | Dažnai (30–79%) | 1 ligoje |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Dažnai (30–79%) | 2 ligose |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Dažnai (30–79%) | 2 ligose |
| ETS1ETS proto-oncogene 1, transcription factor | Dažnai (30–79%) | 1 ligoje |
| EXOSC2exosome component 2 | Dažnai (30–79%) | 1 ligoje |
| FBN1fibrillin 1 | Dažnai (30–79%) | 4 ligose |
| FCGR2BFc gamma receptor IIb | Dažnai (30–79%) | 1 ligoje |
| FCGR3BFc gamma receptor IIIb | Dažnai (30–79%) | 1 ligoje |
| FHfumarate hydratase | Dažnai (30–79%) | 1 ligoje |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Dažnai (30–79%) | 1 ligoje |
| FOXE3forkhead box E3 | Dažnai (30–79%) | 1 ligoje |
| GANABglucosidase II alpha subunit | Dažnai (30–79%) | 2 ligose |
| GATA5GATA binding protein 5 | Dažnai (30–79%) | 1 ligoje |
| GEMIN4gem nuclear organelle associated protein 4 | Dažnai (30–79%) | 1 ligoje |
| GNASGNAS complex locus | Dažnai (30–79%) | 3 ligose |
| GPR101G protein-coupled receptor 101 | Dažnai (30–79%) | 1 ligoje |
| GTF2Igeneral transcription factor IIi | Dažnai (30–79%) | 1 ligoje |
| GTF2IRD1GTF2I repeat domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GTF2IRD2GTF2I repeat domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| H4C3H4 clustered histone 3 | Dažnai (30–79%) | 1 ligoje |
| H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| HCRThypocretin neuropeptide precursor | Dažnai (30–79%) | 1 ligoje |
| HEY2hes related family bHLH transcription factor with YRPW motif 2 | Dažnai (30–79%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Dažnai (30–79%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Dažnai (30–79%) | 2 ligose |
| HMBShydroxymethylbilane synthase | Dažnai (30–79%) | 2 ligose |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Dažnai (30–79%) | 1 ligoje |
| HSD11B1hydroxysteroid 11-beta dehydrogenase 1 | Dažnai (30–79%) | 1 ligoje |
| HTRA1HtrA serine peptidase 1 | Dažnai (30–79%) | 1 ligoje |
| IDUAalpha-L-iduronidase | Dažnai (30–79%) | 1 ligoje |
| IFT172intraflagellar transport 172 | Dažnai (30–79%) | 1 ligoje |
| IFT27intraflagellar transport 27 | Dažnai (30–79%) | 1 ligoje |
| IFT74intraflagellar transport 74 | Dažnai (30–79%) | 1 ligoje |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Dažnai (30–79%) | 1 ligoje |
| IL10interleukin 10 | Dažnai (30–79%) | 1 ligoje |
| IL12Binterleukin 12B | Dažnai (30–79%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Dažnai (30–79%) | 1 ligoje |
| IRF5interferon regulatory factor 5 | Dažnai (30–79%) | 1 ligoje |
| ITGAMintegrin subunit alpha M | Dažnai (30–79%) | 1 ligoje |
| JAZF1JAZF zinc finger 1 | Dažnai (30–79%) | 1 ligoje |
| KCTD1potassium channel tetramerization domain containing 1 | Dažnai (30–79%) | 2 ligose |
| KDM1Alysine demethylase 1A | Dažnai (30–79%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Dažnai (30–79%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Dažnai (30–79%) | 2 ligose |
| LDLRlow density lipoprotein receptor | Dažnai (30–79%) | 1 ligoje |
| LDLRAP1low density lipoprotein receptor adaptor protein 1 | Dažnai (30–79%) | 1 ligoje |
| LIMK1LIM domain kinase 1 | Dažnai (30–79%) | 1 ligoje |
| LIPElipase E, hormone sensitive type | Dažnai (30–79%) | 1 ligoje |
| LOXlysyl oxidase | Dažnai (30–79%) | 1 ligoje |
| LRRC8Cleucine rich repeat containing 8 VRAC subunit C | Dažnai (30–79%) | 1 ligoje |
| LZTFL1leucine zipper transcription factor like 1 | Dažnai (30–79%) | 1 ligoje |
| MAT2Amethionine adenosyltransferase 2A | Dažnai (30–79%) | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Dažnai (30–79%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| MEF2Amyocyte enhancer factor 2A | Dažnai (30–79%) | 1 ligoje |
| METTL27methyltransferase like 27 | Dažnai (30–79%) | 1 ligoje |
| MFAP5microfibril associated protein 5 | Dažnai (30–79%) | 1 ligoje |
| MKKSMKKS centrosomal shuttling protein | Dažnai (30–79%) | 1 ligoje |
| MKS1MKS transition zone complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Dažnai (30–79%) | 1 ligoje |
| MLXIPLMLX interacting protein like | Dažnai (30–79%) | 1 ligoje |
| MOGmyelin oligodendrocyte glycoprotein | Dažnai (30–79%) | 1 ligoje |
| MTFMTmitochondrial methionyl-tRNA formyltransferase | Dažnai (30–79%) | 1 ligoje |
| MYH11myosin heavy chain 11 | Dažnai (30–79%) | 1 ligoje |
| MYLKmyosin light chain kinase | Dažnai (30–79%) | 1 ligoje |
| NCF1neutrophil cytosolic factor 1 | Dažnai (30–79%) | 1 ligoje |
| NDUFAF6NADH:ubiquinone oxidoreductase complex assembly factor 6 | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 3 ligose |
| NKX2-5NK2 homeobox 5 | Dažnai (30–79%) | 1 ligoje |
| NOTCH1notch receptor 1 | Dažnai (30–79%) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Dažnai (30–79%) | 3 ligose |
| OSGEPO-sialoglycoprotein endopeptidase | Dažnai (30–79%) | 1 ligoje |
| P2RY11purinergic receptor P2Y11 | Dažnai (30–79%) | 1 ligoje |
| PAX2paired box 2 | Dažnai (30–79%) | 2 ligose |
| PBX1PBX homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| PCSK9proprotein convertase subtilisin/kexin type 9 | Dažnai (30–79%) | 1 ligoje |
| PDCD1programmed cell death 1 | Dažnai (30–79%) | 1 ligoje |
| PKD1polycystin 1, transient receptor potential channel interacting | Dažnai (30–79%) | 2 ligose |
| PKD2polycystin 2, transient receptor potential cation channel | Dažnai (30–79%) | 2 ligose |
| PLAAT3phospholipase A and acyltransferase 3 | Dažnai (30–79%) | 1 ligoje |
| PORcytochrome p450 oxidoreductase | Dažnai (30–79%) | 2 ligose |
| PRKG1protein kinase cGMP-dependent 1 | Dažnai (30–79%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Dažnai (30–79%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Dažnai (30–79%) | 2 ligose |
| PXKPX domain containing serine/threonine kinase like | Dažnai (30–79%) | 1 ligoje |
| RETret proto-oncogene | Dažnai (30–79%) | 3 ligose |
| RFC2replication factor C subunit 2 | Dažnai (30–79%) | 1 ligoje |
| RNU7-1RNA, U7 small nuclear 1 | Dažnai (30–79%) | 1 ligoje |
| ROBO4roundabout guidance receptor 4 | Dažnai (30–79%) | 1 ligoje |
| SCAPERS-phase cyclin A associated protein in the ER | Dažnai (30–79%) | 1 ligoje |
| SCLT1sodium channel and clathrin linker 1 | Dažnai (30–79%) | 1 ligoje |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Dažnai (30–79%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 2 ligose |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Dažnai (30–79%) | 3 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Dažnai (30–79%) | 2 ligose |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 2 ligose |
| SLC16A2solute carrier family 16 member 2 | Dažnai (30–79%) | 1 ligoje |
| SLC25A11solute carrier family 25 member 11 | Dažnai (30–79%) | 2 ligose |
| SLC35A2solute carrier family 35 member A2 | Dažnai (30–79%) | 1 ligoje |
| SMAD2SMAD family member 2 | Dažnai (30–79%) | 1 ligoje |
| SMAD3SMAD family member 3 | Dažnai (30–79%) | 1 ligoje |
| SMAD4SMAD family member 4 | Dažnai (30–79%) | 3 ligose |
| SMAD6SMAD family member 6 | Dažnai (30–79%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Dažnai (30–79%) | 1 ligoje |
| SPRY2sprouty RTK signaling antagonist 2 | Dažnai (30–79%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 1 ligoje |
| STX1Asyntaxin 1A | Dažnai (30–79%) | 1 ligoje |
| TBL2transducin beta like 2 | Dažnai (30–79%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 1 ligoje |
| TGFB2transforming growth factor beta 2 | Dažnai (30–79%) | 1 ligoje |
| TGFB3transforming growth factor beta 3 | Dažnai (30–79%) | 1 ligoje |
| TGFBR1transforming growth factor beta receptor 1 | Dažnai (30–79%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Dažnai (30–79%) | 1 ligoje |
| TGFBR3transforming growth factor beta receptor 3 | Dažnai (30–79%) | 1 ligoje |
| THBDthrombomodulin | Dažnai (30–79%) | 1 ligoje |
| THSD1thrombospondin type 1 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| THSD4thrombospondin type 1 domain containing 4 | Dažnai (30–79%) | 1 ligoje |
| TLR7toll like receptor 7 | Dažnai (30–79%) | 1 ligoje |
| TMEM127transmembrane protein 127 | Dažnai (30–79%) | 1 ligoje |
| TMEM237transmembrane protein 237 | Dažnai (30–79%) | 1 ligoje |
| TMEM270transmembrane protein 270 | Dažnai (30–79%) | 1 ligoje |
| TMEM67transmembrane protein 67 | Dažnai (30–79%) | 2 ligose |
| TNFAIP3TNF alpha induced protein 3 | Dažnai (30–79%) | 1 ligoje |
| TNFRSF11ATNF receptor superfamily member 11a | Dažnai (30–79%) | 1 ligoje |
| TNFRSF11BTNF receptor superfamily member 11b | Dažnai (30–79%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Dažnai (30–79%) | 2 ligose |
| TNIP1TNFAIP3 interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 2 ligose |
| TREX1three prime repair exonuclease 1 | Dažnai (30–79%) | 2 ligose |
| TRIM32tripartite motif containing 32 | Dažnai (30–79%) | 1 ligoje |
| TTC8tetratricopeptide repeat domain 8 | Dažnai (30–79%) | 1 ligoje |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Dažnai (30–79%) | 1 ligoje |
| UMODuromodulin | Dažnai (30–79%) | 1 ligoje |
| USP48ubiquitin specific peptidase 48 | Dažnai (30–79%) | 1 ligoje |
| USP8ubiquitin specific peptidase 8 | Dažnai (30–79%) | 2 ligose |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 4 ligose |
| VPS37DVPS37D subunit of ESCRT-I | Dažnai (30–79%) | 1 ligoje |
| WDPCPWD repeat containing planar cell polarity effector | Dažnai (30–79%) | 1 ligoje |
| WT1WT1 transcription factor | Dažnai (30–79%) | 4 ligose |
| XPNPEP3X-prolyl aminopeptidase 3 | Dažnai (30–79%) | 1 ligoje |
| YY1AP1YY1 associated protein 1 | Dažnai (30–79%) | 1 ligoje |
| ZNF365zinc finger protein 365 | Dažnai (30–79%) | 1 ligoje |
| ZNRF3zinc and ring finger 3 | Dažnai (30–79%) | 1 ligoje |
| ABCB4ATP binding cassette subfamily B member 4 | Kartais (5–29%) | 1 ligoje |
| ACAT1acetyl-CoA acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| ACP5acid phosphatase 5, tartrate resistant | Kartais (5–29%) | 1 ligoje |
| ADAMTSL4ADAMTS like 4 | Kartais (5–29%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Kartais (5–29%) | 2 ligose |
| ALX4ALX homeobox 4 | Kartais (5–29%) | 1 ligoje |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Kartais (5–29%) | 1 ligoje |
| BNC2basonuclin zinc finger protein 2 | Kartais (5–29%) | 1 ligoje |
| BRCA2BRCA2 DNA repair associated | Kartais (5–29%) | 1 ligoje |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Kartais (5–29%) | 1 ligoje |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Kartais (5–29%) | 1 ligoje |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Kartais (5–29%) | 1 ligoje |
| CMPK2cytidine/uridine monophosphate kinase 2 | Kartais (5–29%) | 1 ligoje |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| EDAectodysplasin A | Kartais (5–29%) | 1 ligoje |
| EDA2Rectodysplasin A2 receptor | Kartais (5–29%) | 1 ligoje |
| EMILIN1elastin microfibril interfacer 1 | Kartais (5–29%) | 1 ligoje |
| EXT2exostosin glycosyltransferase 2 | Kartais (5–29%) | 1 ligoje |
| FIG4FIG4 phosphoinositide 5-phosphatase | Kartais (5–29%) | 1 ligoje |
| FMR1fragile X messenger ribonucleoprotein 1 | Kartais (5–29%) | 1 ligoje |
| FUZfuzzy planar cell polarity protein | Kartais (5–29%) | 1 ligoje |
| GCH1GTP cyclohydrolase 1 | Kartais (5–29%) | 1 ligoje |
| GLAgalactosidase alpha | Kartais (5–29%) | 2 ligose |
| GPC3glypican 3 | Kartais (5–29%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Kartais (5–29%) | 1 ligoje |
| HGDhomogentisate 1,2-dioxygenase | Kartais (5–29%) | 1 ligoje |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Kartais (5–29%) | 1 ligoje |
| HPSE2heparanase 2 (inactive) | Kartais (5–29%) | 1 ligoje |
| HRHR lysine demethylase and nuclear receptor corepressor | Kartais (5–29%) | 1 ligoje |
| IFIH1interferon induced with helicase C domain 1 | Kartais (5–29%) | 1 ligoje |
| IFNGinterferon gamma | Kartais (5–29%) | 1 ligoje |
| IMPDH2inosine monophosphate dehydrogenase 2 | Kartais (5–29%) | 1 ligoje |
| JAM2junctional adhesion molecule 2 | Kartais (5–29%) | 1 ligoje |
| LAMB1laminin subunit beta 1 | Kartais (5–29%) | 1 ligoje |
| LEMD3LEM domain containing 3 | Kartais (5–29%) | 1 ligoje |
| LRIG2leucine rich repeats and immunoglobulin like domains 2 | Kartais (5–29%) | 1 ligoje |
| LRPPRCleucine rich pentatricopeptide repeat containing | Kartais (5–29%) | 1 ligoje |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Kartais (5–29%) | 1 ligoje |
| MC4Rmelanocortin 4 receptor | Kartais (5–29%) | 1 ligoje |
| MED12mediator complex subunit 12 | Kartais (5–29%) | 1 ligoje |
| MEN1menin 1 | Kartais (5–29%) | 1 ligoje |
| MMP14matrix metallopeptidase 14 | Kartais (5–29%) | 1 ligoje |
| MMP2matrix metallopeptidase 2 | Kartais (5–29%) | 1 ligoje |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Kartais (5–29%) | 2 ligose |
| MTRR5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Kartais (5–29%) | 1 ligoje |
| MYORGmyogenesis regulating glycosidase | Kartais (5–29%) | 1 ligoje |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Kartais (5–29%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Kartais (5–29%) | 2 ligose |
| NOTCH3notch receptor 3 | Kartais (5–29%) | 2 ligose |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Kartais (5–29%) | 1 ligoje |
| OFD1OFD1 centriole and centriolar satellite protein | Kartais (5–29%) | 2 ligose |
| PDE11Aphosphodiesterase 11A | Kartais (5–29%) | 2 ligose |
| PDGFBplatelet derived growth factor subunit B | Kartais (5–29%) | 1 ligoje |
| PDGFRBplatelet derived growth factor receptor beta | Kartais (5–29%) | 1 ligoje |
| PHF21APHD finger protein 21A | Kartais (5–29%) | 1 ligoje |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Kartais (5–29%) | 1 ligoje |
| POU3F4POU class 3 homeobox 4 | Kartais (5–29%) | 1 ligoje |
| POU6F2POU class 6 homeobox 2 | Kartais (5–29%) | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Kartais (5–29%) | 1 ligoje |
| PRTN3proteinase 3 | Kartais (5–29%) | 1 ligoje |
| RESTRE1 silencing transcription factor | Kartais (5–29%) | 1 ligoje |
| RNU4ATACRNA, U4atac small nuclear | Kartais (5–29%) | 1 ligoje |
| RRP12ribosomal RNA processing 12 homolog | Kartais (5–29%) | 1 ligoje |
| SLC20A2solute carrier family 20 member 2 | Kartais (5–29%) | 1 ligoje |
| SLC2A10solute carrier family 2 member 10 | Kartais (5–29%) | 2 ligose |
| SLC37A4solute carrier family 37 member 4 | Kartais (5–29%) | 3 ligose |
| SLC7A7solute carrier family 7 member 7 | Kartais (5–29%) | 1 ligoje |
| TRIM28tripartite motif containing 28 | Kartais (5–29%) | 1 ligoje |
| TRIP13thyroid hormone receptor interactor 13 | Kartais (5–29%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Kartais (5–29%) | 1 ligoje |
| VAC14VAC14 component of PIKFYVE complex | Kartais (5–29%) | 1 ligoje |
| VANGL1VANGL planar cell polarity protein 1 | Kartais (5–29%) | 1 ligoje |
| WRNWRN RecQ like helicase | Kartais (5–29%) | 1 ligoje |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Kartais (5–29%) | 1 ligoje |
| XYLT1xylosyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| XYLT2xylosyltransferase 2 | Kartais (5–29%) | 1 ligoje |
| ZFXzinc finger protein X-linked | Kartais (5–29%) | 1 ligoje |
| ZMPSTE24zinc metallopeptidase STE24 | Kartais (5–29%) | 1 ligoje |
| ACBD6acyl-CoA binding domain containing 6 | Retai (1–4 %) | 1 ligoje |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Retai (1–4 %) | 1 ligoje |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Retai (1–4 %) | 1 ligoje |
| LMO1LIM domain only 1 | Retai (1–4 %) | 1 ligoje |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Retai (1–4 %) | 1 ligoje |
| PHOX2Bpaired like homeobox 2B | Retai (1–4 %) | 1 ligoje |
| ACVRL1activin A receptor like type 1 | Neužfiksuota | 1 ligoje |
| ARHGAP31Rho GTPase activating protein 31 | Neužfiksuota | 1 ligoje |
| BMPR2bone morphogenetic protein receptor type 2 | Neužfiksuota | 1 ligoje |
| BSNDbarttin CLCNK type accessory subunit beta | Neužfiksuota | 1 ligoje |
| CCDC28Bcoiled-coil domain containing 28B | Neužfiksuota | 1 ligoje |
| CD2APCD2 associated protein | Neužfiksuota | 1 ligoje |
| CFHcomplement factor H | Neužfiksuota | 1 ligoje |
| CFHR1complement factor H related 1 | Neužfiksuota | 1 ligoje |
| CFHR3complement factor H related 3 | Neužfiksuota | 1 ligoje |
| CLCNKAchloride voltage-gated channel Ka | Neužfiksuota | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Neužfiksuota | 1 ligoje |
| COL4A3collagen type IV alpha 3 chain | Neužfiksuota | 2 ligose |
| COL4A4collagen type IV alpha 4 chain | Neužfiksuota | 2 ligose |
| COQ7coenzyme Q7, hydroxylase | Neužfiksuota | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Neužfiksuota | 1 ligoje |
| CUL3cullin 3 | Neužfiksuota | 1 ligoje |
| CYP21A2cytochrome P450 family 21 subfamily A member 2 | Neužfiksuota | 1 ligoje |
| EPORerythropoietin receptor | Neužfiksuota | 1 ligoje |
| FGAfibrinogen alpha chain | Neužfiksuota | 1 ligoje |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Neužfiksuota | 1 ligoje |
| G6PC1glucose-6-phosphatase catalytic subunit 1 | Neužfiksuota | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Neužfiksuota | 1 ligoje |
| HBBhemoglobin subunit beta | Neužfiksuota | 1 ligoje |
| INF2inverted formin 2 | Neužfiksuota | 1 ligoje |
| ITGA8integrin subunit alpha 8 | Neužfiksuota | 1 ligoje |
| KLHL3kelch like family member 3 | Neužfiksuota | 1 ligoje |
| KRT18keratin 18 | Neužfiksuota | 1 ligoje |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Neužfiksuota | 1 ligoje |
| LRP6LDL receptor related protein 6 | Neužfiksuota | 1 ligoje |
| MGPmatrix Gla protein | Neužfiksuota | 1 ligoje |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Neužfiksuota | 1 ligoje |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Neužfiksuota | 1 ligoje |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Neužfiksuota | 1 ligoje |
| MT-CYBmitochondrially encoded cytochrome b | Neužfiksuota | 1 ligoje |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Neužfiksuota | 1 ligoje |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Neužfiksuota | 1 ligoje |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Neužfiksuota | 1 ligoje |
| MT-TCmitochondrially encoded tRNA-Cys (UGU/C) | Neužfiksuota | 1 ligoje |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Neužfiksuota | 1 ligoje |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Neužfiksuota | 1 ligoje |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Neužfiksuota | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Neužfiksuota | 1 ligoje |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Neužfiksuota | 1 ligoje |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Neužfiksuota | 1 ligoje |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Neužfiksuota | 1 ligoje |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Neužfiksuota | 1 ligoje |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Neužfiksuota | 1 ligoje |
| MUC1mucin 1, cell surface associated | Neužfiksuota | 1 ligoje |
| NFIXnuclear factor I X | Neužfiksuota | 1 ligoje |
| NOTCH2notch receptor 2 | Neužfiksuota | 1 ligoje |
| NR3C2nuclear receptor subfamily 3 group C member 2 | Neužfiksuota | 1 ligoje |
| NSMCE2NSE2 SUMO ligase component of SMC5/6 complex | Neužfiksuota | 1 ligoje |
| PAM16presequence translocase associated motor 16 | Neužfiksuota | 1 ligoje |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Neužfiksuota | 1 ligoje |
| SERPINA6serpin family A member 6 | Neužfiksuota | 1 ligoje |
| SH2B3SH2B adaptor protein 3 | Neužfiksuota | 1 ligoje |
| STAT2signal transducer and activator of transcription 2 | Neužfiksuota | 1 ligoje |
| SUGCTsuccinyl-CoA:glutarate-CoA transferase | Neužfiksuota | 1 ligoje |
| TMEM70transmembrane protein 70 | Neužfiksuota | 1 ligoje |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Neužfiksuota | 1 ligoje |
| WDR35WD repeat domain 35 | Neužfiksuota | 1 ligoje |
| WNK4WNK lysine deficient protein kinase 4 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites